Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup

Imagem de Miniatura
Arquivos
art_DECKER_Extracorporeal_Treatment_for_Lithium_Poisoning_Systematic_Review_and_2015.PDF (672.02 KB)
Citações na Scopus
121
Tipo de produção
article
Data de publicação
2015
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC NEPHROLOGY
Autores
DECKER, Brian S.
GOLDFARB, David S.
DARGAN, Paul I.
FRIESEN, Marjorie
GOSSELIN, Sophie
HOFFMAN, Robert S.
LAVERGNE, Valery
NOLIN, Thomas D.
GHANNOUM, Marc
Citação
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, v.10, n.5, p.875-887, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The Extracorporeal Treatments in Poisoning Workgroup was created to provide evidence-based recommendations on the use of extracorporeal treatments in poisoning. Here, the EXTRIP workgroup presents its recommendations for lithium poisoning. After a systematic literature search, clinical and toxicokinetic data were extracted and summarized following a predetermined format. The entire workgroup voted through a two-round modified Delphi method to reach a consensus on voting statements. A RAND/UCLA Appropriateness Method was used to quantify disagreement, and anonymous votes were compiled and discussed in person. A second vote was conducted to determine the final workgroup recommendations. In total, 166 articles met inclusion criteria, which were mostly case reports, yielding a very low quality of evidence for all recommendations. A total of 418 patients were reviewed, 228 of which allowed extraction of patient-level data. The workgroup concluded that lithium is dialyzable (Level of evidence=A) and made the following recommendations: Extracorporeal treatment is recommended in severe lithium poisoning (1D). Extracorporeal treatment is recommended if kidney function is impaired and the [Li+] is >4.0 mEq/L, or in the presence of a decreased level of consciousness, seizures, or life- threatening dysrhythmias irrespective of the [Li+] (1D). Extracorporeal treatment is suggested if the [Li+] is >5.0 mEq/L, significant confusion is present, or the expected time to reduce the [Li+] to <1.0 mEq/L is >36 hours (2D). Extracorporeal treatment should be continued until clinical improvement is apparent or [Li+] is <1.0 mEq/L (1D). Extracorporeal treatments should be continued for a minimum of 6 hours if the [Li+] is not readily measurable (1D). Hemodialysis is the preferred extracorporeal treatment (1D), but continuous RRT is an acceptable alternative (1D). The workgroup supported the use of extracorporeal treatment in severe lithium poisoning. Clinical decisions on when to use extracorporeal treatment should take into account the [Li+], kidney function, pattern of lithium toxicity, patient's clinical status, and availability of extracorporeal treatments.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/26858
Referências
  1. ACHONG MR, 1975, CAN MED ASSOC J, V112, P868
  2. Adityanjee, 2005, CLIN NEUROPHARMACOL, V28, P38
  3. AGARWAL SK, 1993, INT J ARTIF ORGANS, V16, P20
  4. ALLAIN P, 1973, THERAPIE, V28, P1135
  5. AMDISEN A, 1969, LANCET, V2, P213
  6. AMDISEN A, 1988, MED TOXICOL ADV DRUG, V3, P18, DOI 10.1007/BF03259929
  7. ANANTH J, 1992, LITHIUM, V3, P139
  8. [Anonymous], 2004, J TOXICOL CLIN TOXIC, V42, P843
  9. APTE SN, 1983, ANN NEUROL, V13, P453, DOI 10.1002/ana.410130414
  10. Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
  11. Bailey AR, 2011, CRIT CARE RESUSC, V13, P120
  12. Bailey B, 2000, THER DRUG MONIT, V22, P650, DOI 10.1097/00007691-200012000-00002
  13. Bailey B, 2000, CLIN NEPHROL, V54, P388
  14. BAZILINSKI N, 1986, INT J ARTIF ORGANS, V9, P5
  15. Beckmann U, 2001, J TOXICOL-CLIN TOXIC, V39, P393, DOI 10.1081/CLT-100105160
  16. BEJAR JM, 1985, CLIN NEUROPHARMACOL, V8, P379, DOI 10.1097/00002826-198512000-00010
  17. BELLOMO R, 1991, CRIT CARE MED, V19, P836, DOI 10.1097/00003246-199106000-00018
  18. BELLOMO R, 1992, LITHIUM, V3, P245
  19. Benowitz N, 2011, POISONING DRUG OVERD
  20. Benson BE, 2013, CLIN TOXICOL, V51, P140, DOI 10.3109/15563650.2013.770154
  21. Bertaso L., 1993, Acta Anaesthesiologica Italica, V44, P261
  22. Bilanakis N, 2004, PROG NEURO-PSYCHOPH, V28, P201, DOI 10.1016/S0278-5846(03)00167-2
  23. Bjarnason NH, 2006, THER DRUG MONIT, V28, P262, DOI 10.1097/01.ftd.0000183386.35018.86
  24. Borras-Blasco J, 2007, SOUTH MED J, V100, P321, DOI 10.1097/01.smj.0000257619.25995.c4
  25. Bosak Adam R, 2014, J Med Toxicol, V10, P303, DOI 10.1007/s13181-013-0366-z
  26. Bosinski T, 1998, AM J EMERG MED, V16, P98, DOI 10.1016/S0735-6757(98)90080-8
  27. Bosse George M., 1992, Journal of Emergency Medicine, V10, P719, DOI 10.1016/0736-4679(92)90531-W
  28. Bouchard J, 2014, SEMIN DIALYSIS, V27, P371, DOI 10.1111/sdi.12247
  29. BOUFFARD Y, 1984, PRESSE MED, V13, P1456
  30. Branger B, 2000, NEPHROLOGIE, V21, P291
  31. BROWN EA, 1981, BRIT J CLIN PRACT, V35, P90
  32. Camacho Pulido JA, 1995, FARM CLIN, V12, P509
  33. Canan Fatih, 2008, Cases J, V1, P156, DOI 10.1186/1757-1626-1-156
  34. Lopez JC, 2012, HEMODIAL INT, V16, P407, DOI 10.1111/j.1542-4758.2012.00669.x
  35. Cavaliere F, 1984, Recenti Prog Med, V75, P877
  36. Chebrolu SB, 2005, CHINESE MED J-PEKING, V118, P1405
  37. Chen L, 2010, AUST NZ J PSYCHIAT, V44, P95, DOI 10.3109/00048670903393696
  38. Christian MR, 2011, CLIN TOXICOL, V49, P540
  39. Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805
  40. CLENDENINN NJ, 1982, J TOXICOL-CLIN TOXIC, V19, P341, DOI 10.3109/15563658208992488
  41. Daly F, 2011, TOXICOLOGY HDB, P260
  42. Danel V, 2001, JEUR, V14, P134
  43. De Ridder K, 2002, TIJDSCHR GENEESKD, V58, P769
  44. Deguigne MB, 2013, CLIN TOXICOL, V51, P243, DOI 10.3109/15563650.2013.782409
  45. Desatnik P, 1995, Lakartidningen, V92, P643
  46. Dhondt A, 2005, AM J KIDNEY DIS, V46, pE95, DOI 10.1053/j.ajkd.2005.08.001
  47. DIAS N, 1973, NEPHRON, V10, P246, DOI 10.1159/000180194
  48. Diaz de Leon Ponce M, 1983, REV MED I MEX SEGURO, V21, P521
  49. Dieryck J, 1983, TIJDSCHR GENEESKD, V39, P269
  50. Dupuis RE, 1996, ANN PHARMACOTHER, V30, P356, DOI 10.1177/106002809603000406
  51. ELMALLAKH RS, 1987, VET HUM TOXICOL, V29, P143
  52. Eyer F, 2006, J CLIN PSYCHOPHARM, V26, P325, DOI 10.1097/01.jcp.0000218405.02738.b3
  53. Favarel-Garrigues B, 1972, Ann Med Psychol (Paris), V1, P253
  54. FAVIN FD, 1988, J TOXICOL-CLIN TOXIC, V26, P443, DOI 10.3109/15563658809038560
  55. FENVES AZ, 1984, SOUTHERN MED J, V77, P1472, DOI 10.1097/00007611-198411000-00030
  56. Fiaccadori E, 2008, NEPHROL DIAL TRANSPL, V24, P329
  57. FINLEY PR, 1995, CLIN PHARMACOKINET, V29, P172, DOI 10.2165/00003088-199529030-00004
  58. Fitch K, 2011, RAND UCLA APPROPRIAT
  59. Fountain J, 2014, TOXINZ
  60. FRIEDBERG RC, 1991, CLIN CHEM, V37, P1205
  61. GADALLAH MF, 1988, MINER ELECTROL METAB, V14, P146
  62. GALLARDO MB, 1988, REV CLIN ESP, V183, P156
  63. GATELL AA, 1989, REV CLIN ESP, V185, P195
  64. Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217
  65. Ghannoum M, 2014, CLIN TOXICOL PHILA, V30, P1
  66. Ghannoum M, 2014, SEMIN DIALYSIS, V27, P362, DOI 10.1111/sdi.12228
  67. Ghannoum M, 2012, CLIN J AM SOC NEPHRO, V7, P1682, DOI 10.2215/CJN.01940212
  68. Ghannoum M, 2011, ADV CHRONIC KIDNEY D, V18, P160, DOI 10.1053/j.ackd.2011.01.008
  69. Ghannoum M, 2010, CLIN TOXICOL, V48, P34, DOI 10.3109/15563650903344785
  70. Gill J, 2003, PHARMACOTHERAPY, V23, P811, DOI 10.1592/phco.23.6.811.32179
  71. Giuliani E, 2010, MINERVA ANESTESIOL, V76, P463
  72. GODDARD J, 1991, BRIT MED J, V302, P1267, DOI 10.1136/bmj.302.6787.1267
  73. Goodman JW, 2006, SEMIN DIALYSIS, V19, P402, DOI 10.1111/j.1525-139X.2006.00194.x
  74. Gosselin S, 2014, CLIN TOXICOL, V52, P856, DOI 10.3109/15563650.2014.946994
  75. GREEN ST, 1985, BRIT MED J, V290, P517, DOI 10.1136/bmj.290.6467.517
  76. Greller HA, 2011, GOLDFRANKS TOXICOLOG, P142
  77. GROLEAU G, 1987, AM J EMERG MED, V5, P527, DOI 10.1016/0735-6757(87)90178-1
  78. Groleau Georgina, 1994, Emergency Medicine Clinics of North America, V12, P511
  79. GUERIN JM, 1990, ARCH INTERN MED, V150, P920, DOI 10.1001/archinte.1990.00390160160051
  80. Haghfelt T, 1971, Nord Med, V86, P1465
  81. Handler J, 2009, J CLIN HYPERTENS, V11, P738, DOI 10.1111/j.1751-7176.2009.00181.x
  82. HANNA ME, 1990, J CLIN PSYCHOPHARM, V10, P379, DOI 10.1097/00004714-199010000-00027
  83. HANSEN HE, 1978, Q J MED, V47, P123
  84. HANSEN HE, 1979, ACTA MED SCAND, V205, P593
  85. Havle N, 2009, KLIN PSIKOFARMAKOL B, V19, P206
  86. Hazouard E, 1999, NEPHROL DIAL TRANSPL, V14, P1605, DOI 10.1093/ndt/14.6.1605
  87. Heinrich TW, 2006, PSYCHOSOMATICS, V47, P264, DOI 10.1176/appi.psy.47.3.264
  88. de Pablo EH, 2008, AN MED INTERN, V25, P209
  89. Holubek WJ, 2008, KIDNEY INT, V74, P1327, DOI 10.1038/ki.2008.462
  90. HUGHES PM, 1984, NEW ZEAL MED J, V97, P23
  91. HUMBERT G, 1974, SEM HOP PARIS, V50, P509
  92. Ilagan Michael C, 2002, Del Med J, V74, P263
  93. JACOBSEN D, 1987, J TOXICOL-CLIN TOXIC, V25, P81, DOI 10.3109/15563658708992615
  94. JAEGER A, 1993, J TOXICOL-CLIN TOXIC, V31, P429, DOI 10.3109/15563659309000411
  95. JAEGER A, 1985, J TOXICOL-CLIN TOXIC, V23, P501
  96. Jenniskens-Bruins J J, 1992, Tijdschr Kindergeneeskd, V60, P76
  97. JENSEN H, 1975, EUR J CLIN PHARMACOL, V8, P285, DOI 10.1007/BF00567130
  98. Jensen J P, 1974, Ugeskr Laeger, V136, P1505
  99. JOSEPHS W, 1988, Intensivmedizin, V25, P241
  100. Kansagra A, 2010, CRIT CARE MED, V38, pA274
  101. Kansagra AJ, 2014, AM J THER, V21, pE31, DOI 10.1097/MJT.0b013e3182204feb
  102. KASAHARA H, 1994, JPN J PSYCHIAT NEUR, V48, P1
  103. Kayrak M, 2010, CARDIOL J, V17, P404
  104. Kayrak M, 2010, ANN NONINVAS ELECTRO, V15, P289, DOI 10.1111/j.1542-474X.2010.00366.x
  105. KELLEHER SP, 1986, ARCH INTERN MED, V146, P1839, DOI 10.1001/archinte.146.9.1839
  106. Kerbusch T, 2002, PHARMACOL TOXICOL, V90, P243, DOI 10.1034/j.1600-0773.2002.900503.x
  107. Khasraw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-131
  108. Kirschner RI, 2011, CLIN TOXICOL, V49, P515
  109. Kleinert A, 1991, Pol Tyg Lek, V46, P464
  110. KONDZIELA JR, 1984, HOSP COMMUNITY PSYCH, V35, P727
  111. Lai CL, 2000, J FORMOS MED ASSOC, V99, P66
  112. LANG E, 1974, ACTIV NERV SUPER, V16, P197
  113. LAVENDER S, 1973, POSTGRAD MED J, V49, P277, DOI 10.1136/pgmj.49.570.277
  114. Lavergne V, 2014, SEMIN DIALYSIS, V27, P407, DOI 10.1111/sdi.12251
  115. Lavergne V, 2012, CLIN TOXICOL, V50, P403, DOI 10.3109/15563650.2012.683436
  116. LAWLER PG, 1986, ANAESTHESIA, V41, P623, DOI 10.1111/j.1365-2044.1986.tb13056.x
  117. Leblanc M, 1996, AM J KIDNEY DIS, V27, P365, DOI 10.1016/S0272-6386(96)90359-5
  118. Lee DC, 2013, MEDSCAPE
  119. Lee YC, 2011, HUM EXP TOXICOL, V30, P528, DOI 10.1177/0960327110377524
  120. LINAKIS JG, 1989, PHARMACOL TOXICOL, V65, P387, DOI 10.1111/j.1600-0773.1989.tb01194.x
  121. Lins R, 1980, Ned Tijdschr Geneeskd, V124, P545
  122. Liu WC, 2001, J INT MED TAIWAN, V12, P241
  123. Long AN, 2011, J INVEST MED, V59, P372
  124. Lum G, 2007, LABMEDICINE, V38, P667, DOI 10.1309/CGA4FKTUDK2JWF46
  125. Lundholm Birgitta, 2010, Lakartidningen, V107, P496
  126. Mactier R, 2014, AM J KIDNEY DIS, V64, P347, DOI 10.1053/j.ajkd.2014.04.031
  127. Manor E, 1983, ARCH TOXICOL, V53, P384
  128. Manto M, 1996, NEUROL RES, V18, P416
  129. Mardini J, 2014, SEMIN DIALYSIS, V27, P402, DOI 10.1111/sdi.12245
  130. MARSHALL SM, 1981, DRUG INTEL CLIN PHAR, V15, P598
  131. MASON RW, 1978, CLIN PHARMACOKINET, V3, P241, DOI 10.2165/00003088-197803030-00004
  132. MATEER JR, 1982, ANN EMERG MED, V11, P208, DOI 10.1016/S0196-0644(82)80500-3
  133. McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X
  134. Meertens JHJM, 2009, EUR J INTERN MED, V20, pE70, DOI 10.1016/j.ejim.2008.07.013
  135. Megarbane B, 2002, CLIN TOXICOL PHILA, V40, P313
  136. Meltzer E, 2002, ISRAEL MED ASSOC J, V4, P265
  137. Meltzer H., 2012, BASIC CLIN PHARM, P501
  138. Menegueti MG, 2012, INDIAN J CRIT CARE M, V16, P109, DOI 10.4103/0972-5229.99134
  139. Menghini VV, 2000, AM J KIDNEY DIS, V36, part. no., DOI 10.1053/ajkd.2000.16224
  140. Meyer JM, 2011, GOODMAN GILMANS PHAR, P417
  141. Meyer RJ, 2001, AM J KIDNEY DIS, V37, P1044, DOI 10.1016/S0272-6386(05)80022-8
  142. Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906
  143. [National Poisons Information Services NPIS], 2014, TOXB
  144. Newland KD, 2002, AM J EMERG MED, V20, P67, DOI 10.1053/ajem.2002.29553
  145. Nishiwaki T, 1996, INT J GYNECOL OBSTET, V52, P191, DOI 10.1016/0020-7292(95)02591-X
  146. NURNBERGER JI, 1985, J NERV MENT DIS, V173, P316, DOI 10.1097/00005053-198505000-00015
  147. Oakley PW, 2001, AUST NZ J PSYCHIAT, V35, P833, DOI 10.1046/j.1440-1614.2001.00963.x
  148. Oakley PW, 2000, J TOXICOL-CLIN TOXIC, V38, P333, DOI 10.1081/CLT-100100941
  149. OCONNOR J, 1982, NEW ZEAL MED J, V95, P790
  150. Offerman SR, 2010, CLIN TOXICOL, V48, P443, DOI 10.3109/15563650.2010.482533
  151. OKUSA MD, 1994, AM J MED, V97, P383, DOI 10.1016/0002-9343(94)90308-5
  152. Oray NC, 2011, ANADOLU PSIKIYATR DE, V12, P198
  153. Ouellet G, 2014, SEMIN DIALYSIS, V27, P342, DOI 10.1111/sdi.12238
  154. PAHOLPAK S, 1989, Journal of the Medical Association of Thailand, V72, P112
  155. Pandey S, 2008, NEUROL INDIA, V56, P484, DOI 10.4103/0028-3886.44816
  156. Peces R, 2006, NEFROLOGIA, V26, P372
  157. Peces R, 2001, NEPHROL DIAL TRANSPL, V16, P1301, DOI 10.1093/ndt/16.6.1301-a
  158. Pedersen R S, 1976, Ugeskr Laeger, V138, P3325
  159. Perale L, 2010, J EMERG MED, V38, P502, DOI 10.1016/j.jemermed.2008.02.064
  160. PERRIER A, 1991, CHEST, V100, P863, DOI 10.1378/chest.100.3.863
  161. Perrone J, 2014, UPTODATE
  162. PERROT D, 1982, J TOXICOL CLIN EXPER, V2, P49
  163. Phillips BD, 2008, THYROID, V18, P651, DOI 10.1089/thy.2008.0263
  164. Plenge Ulla, 2008, Ugeskr Laeger, V170, P354
  165. POND SM, 1991, MED J AUSTRALIA, V154, P617
  166. Porto FHG, 2009, J NEUROL SCI, V277, P172, DOI 10.1016/j.jns.2008.10.010
  167. Prencipe M, 2013, G ITAL NEFROL, V30
  168. PRINGUEY D, 1981, AM J PSYCHIAT, V138, P249
  169. Puhr Joshua, 2008, J Med Toxicol, V4, P170
  170. Roberts DM, 2014, SEMIN DIALYSIS, V27, P390, DOI 10.1111/sdi.12235
  171. ROSE SR, 1988, DRUG INTEL CLIN PHAR, V22, P691
  172. ROSEN PB, 1983, ANN NEUROL, V13, P221, DOI 10.1002/ana.410130232
  173. Sahin Yildiz T, 2006, ANESTEZI DERGISI, V14, P210
  174. Satar Salim, 2006, Am J Ther, V13, P404, DOI 10.1097/01.mjt.0000174344.51554.43
  175. Sato Y, 2013, THYROID, V23, P766, DOI 10.1089/thy.2012.0140
  176. SAXENA S, 1988, BRIT J PSYCHIAT, V152, P853, DOI 10.1192/bjp.152.6.853
  177. SCHINDLER BA, 1993, PSYCHOSOMATICS, V34, P521, DOI 10.1016/S0033-3182(93)71828-9
  178. Schmidt JJ, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-49
  179. Schmitt C, 2009, THERAPIE, V64, P55, DOI 10.2515/therapie/2009010
  180. SCOBLE JE, 1990, NEPHROL DIAL TRANSPL, V5, P904, DOI 10.1093/ndt/5.10.904
  181. Slordal L, 2003, BRIT J CLIN PHARMACO, V55, P413, DOI 10.1046/j.1365-2125.2003.01777.x
  182. Smith D, 2003, J ROY SOC MED, V96, P590, DOI 10.1258/jrsm.96.12.590
  183. SMITH SW, 1991, ANN EMERG MED, V20, P536, DOI 10.1016/S0196-0644(05)81610-5
  184. Sood MM, 2007, CAN MED ASSOC J, V176, P921, DOI 10.1503/cmaj.061057
  185. Swartz C M, 1995, Ann Clin Psychiatry, V7, P207, DOI 10.3109/10401239509149627
  186. SWARTZ CM, 1994, J CLIN PHARMACOL, V34, P865, DOI 10.1002/j.1552-4604.1994.tb02053.x
  187. SZERLIP HM, 1992, AM J NEPHROL, V12, P116, DOI 10.1159/000168430
  188. Takahashi Tetsuya, 2011, Chudoku Kenkyu, V24, P42
  189. Talwalkar N C, 1986, J Assoc Physicians India, V34, P597
  190. Tapolyai M, 2002, NEPHRON, V90, P213, DOI 10.1159/000049045
  191. TEMTE JL, 1994, JAMA-J AM MED ASSOC, V272, P1723, DOI 10.1001/jama.272.22.1723
  192. THIEL A, 1993, ACTA PSYCHIAT SCAND, V88, P289, DOI 10.1111/j.1600-0447.1993.tb03459.x
  193. THORNLEYBROWN D, 1992, ANN INTERN MED, V116, P739, DOI 10.7326/0003-4819-116-9-739
  194. Timmer RT, 1999, J AM SOC NEPHROL, V10, P666
  195. Treysman L, 2010, CLIN TOXICOL, V48, P647
  196. TUNKEL AR, 1988, ARCH INTERN MED, V148, P253, DOI 10.1001/archinte.148.1.253
  197. Unei H, 2008, YAKUGAKU ZASSHI, V128, P165, DOI 10.1248/yakushi.128.165
  198. Uzu Takashi, 2001, Journal of the Japan Diabetes Society, V44, P767
  199. van Bommel EFH, 2000, AM J NEPHROL, V20, P408, DOI 10.1159/000013627
  200. Vasileiou I, 2011, FUND CLIN PHARMACOL, V25, P48, DOI 10.1111/j.1472-8206.2009.00809.x
  201. Vermeire S, 2010, ACTA CLIN BELG, V65, P127, DOI 10.1179/acb.2010.025
  202. Voiculescu A., 1995, Intensivmedizin und Notfallmedizin, V32, P433
  203. VONHARTITZSCH B, 1972, BMJ-BRIT MED J, V4, P757, DOI 10.1136/bmj.4.5843.757
  204. WANG S-Y, 1985, Taiwan yixuehui zazhi, V84, P960
  205. Wanscher M C, 1986, Ugeskr Laeger, V148, P2160
  206. Waring W Stephen, 2006, Toxicol Rev, V25, P221, DOI 10.2165/00139709-200625040-00003
  207. White B, 2008, INT J CARDIOL, V125, pE48, DOI 10.1016/j.ijcard.2006.12.051
  208. WHYBROW PC, 1969, LANCET, V1, P839
  209. Wilkinson Angela, 2009, Practitioner, V253, P28
  210. WILSON JHP, 1971, BRIT MED J, V2, P749, DOI 10.1136/bmj.2.5764.749
  211. Yates C, 2014, SEMIN DIALYSIS, V27, P381, DOI 10.1111/sdi.12227
  212. ZABANEH RI, 1995, ARTIF ORGANS, V19, P94, DOI 10.1111/j.1525-1594.1995.tb02251.x
  213. Zallo Atxutegi E, 2008, PSIQUIATRIA BIOL, V15, P56
  214. ZETIN M, 1981, AM J PSYCHIAT, V138, P1387
  215. ZINGRAFF J, 1975, NOUV PRESSE MED, V4, P3183

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/12